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Statement of findings
We investigated the role of Fcg receptors (FcgRs) on synovial macrophages in immune-
complex-mediated arthritis (ICA). ICA elicited in knee joints of C57BL/6 mice caused a
short-lasting, florid inflammation and reversible loss of proteoglycans (PGs), moderate
chondrocyte death, and minor erosion of the cartilage. In contrast, when ICA was induced in
knee joints of Fc receptor (FcR) g-chain–/– C57BL/6 mice, which lack functional FcgRI and
RIII, inflammation and cartilage destruction were prevented. When ICA was elicited in
DBA/1 mice, a very severe, chronic inflammation was observed, and significantly more
chondrocyte death and cartilage erosion than in arthritic C57BL/6 mice. The synovial lining
and peritoneal macrophages of naïve DBA/1 mice expressed a significantly higher level of
FcgRs than was seen in C57BL/6 mice. Moreover, elevated and prolonged expression of
IL-1 was found after stimulation of these cells with immune complexes. Zymosan or
streptococcal cell walls caused comparable inflammation and only mild cartilage destruction
in all strains. We conclude that FcgR expression on synovial macrophages may be related to
the severity of synovial inflammation and cartilage destruction during ICA.
Keywords: autoimmunity, cytokines, Fc receptors, inflammation, macrophages
Received: 15 April 2000
Revisions requested: 8 May 2000
Revisions received: 13 July 2000
Accepted: 31 July 2000
Published: 31 August 2000
Arthritis Res 2000, 2:489–503
The electronic version of this article can be found online at
http://arthritis-research.com/content/2/6/489
© Current Science Ltd (Print ISSN 1465-9905; Online ISSN 1465-9913)
ABC = avidin biotin complex; BSA = bovine serum albumin; C = complement; CD = cluster of differentiation; CIA = collagen-induced arthritis;
DMEM = Dulbecco’s modified Eagle’s medium; DMPA = N,N-dimethyl-1,3-propanediamine; ELISA = enzyme-linked immunosorbent assay;
F(ab¢)2 = antigen binding portion of IgG that was cleaved using pepsin; FACS = fluorescence-activated cell sorter; Fc = crystallisable fragment (of
immunoglobulin); FceR = Fce receptor; FcgR = Fcg receptor; FcR = Fc receptor; FcR g-chain–/– (mice) = knockout mice lacking g chain; FCS = fetal
calf serum; FITC = fluorescein isothiocyanate; GAPDH = glyceraldehyde-3-phosphate dehydrogenase; H&E = haematoxylin/eosin; HAGG = heat-
aggregated gamma globulin; ICA = immune-complex-mediated arthritis; IFN = interferon; IL = interleukin; IL-1Ra = IL-1-receptor antagonist; 
mAb = monoclonal antibody; MCP = monocyte chemoattractant protein; MIP = macrophage inflammatory protein; NTP = nucleoside triphosphate;
PBS = phosphate-buffered saline; PCR = polymerase chain reaction; PG = proteoglycan; PLL = poly-L-lysine; PMN = polymorphonuclear
neutrophil; RA = rheumatoid arthritis; RIA = radioimmunoassay; RPMI (medium) = Roswell Park Memorial Institute (medium); RT-PCR = reverse-
transcription polymerase chain reaction; SCW = streptococcal cell wall; TcR = T cell receptor; TGF = transforming growth factor.
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Introduction:  Fcg receptors (FcgRs) present on cells of the
haematopoietic lineage communicate with IgG-containing
immune complexes that are abundant in the synovial tissue of
patients with rheumatoid arthritis (RA). In mice, three classes of
FcgR (RI, RII, and RIII) have been described. Binding of these
receptors leads to either activation (FcgRI and RIII) or
deactivation (FcgRII) of intracellular transduction pathways.
Together, the expression of activating and inhibitory receptors
is thought to drive immune-complex-mediated diseases.
Earlier studies in our laboratory showed that macrophages of
the synovial lining are of utmost importance in the onset and
propagation of immune-complex-driven arthritic diseases.
Selective depletion of macrophages in the joint downregulated
both inflammation and cartilage destruction. As all three
classes of FcgR are expressed on synovial macrophages, these
cells are among the first that come in contact with immune
complexes deposited in the joint. Recently, we observed that
when immune complexes were injected into the knee joints of
mice, strains susceptible to collagen-type-II arthritis (DBA/1,
B10.RIII) developed more severe arthritis than nonsusceptible
strains did, or even developed chronic arthritis. One reason
why these strains are more susceptible might be their higher
levels of FcgRs on macrophage membranes. To test this
hypothesis, we investigated the role of FcgRs in inflammation
and cartilage damage during immune-complex-mediated
arthritis (ICA). First, we studied arthritis and subsequent
cartilage damage in mice lacking functional FcgRI and RIII (FcR
g-chain–/– mice). Next, DBA/1 mice, which are prone to develop
collagen-type-II arthritis (‘collagen-induced arthritis’; CIA) and
are hypersensitive to immune complexes, were compared with
control C57BL/6 mice as regards cartilage damage and the
expression and function of FcgRs on their macrophages.
Aims: To examine whether FcgR expression on macrophages is
related to severity of synovial inflammation and cartilage
destruction during immune-complex-mediated joint inflammation.
Methods: ICA was induced in three strains of mice (FcR
g-chain–/–, C57BL/6, and DBA/1, which have, respectively, no
functional FcgRI and RIII, intermediate basal expression of
FcgRs, and high basal expression of FcgRs) by passive
immunisation using rabbit anti-lysozyme antibodies, followed by
poly-L-lysine lysozyme injection into the right knee joint 1 day
later. In other experiments, streptococcal-cell-wall (SCW)- or
zymosan-induced arthritis was induced by injecting SCW
(25 mg) or zymosan (180 mg) directly into the knee joint. At
several time points after arthritis induction, knee joints were
dissected and studied either histologically (using
haematoxylin/eosin or safranin O staining) or immuno-
histochemically. The arthritis severity and the cartilage damage
were scored separately on an arbitrary scale of 0–3.
FcgRs were immunohistochemically detected using the
monoclonal antibody 2.4G2, which detects both FcgRII and
RIII. Deposition of IgG and C3c in the arthritic joint tissue was
also detected immunohistochemically. Expression of FcgRs by
murine peritoneal macrophages was measured using a
fluorescence-activated cell sorter (FACS).
Peritoneal macrophages were stimulated using heat-
aggregated gamma globulins (HAGGs), and production of IL-1
was measured using a bioassay. To assess the levels of IL-1
and its receptor antagonist (IL-1Ra) during arthritis, tissue was
dissected and washed in RPMI medium. Washouts were
tested for levels of IL-1 and IL-1Ra using radioimmunoassay
and enzyme-linked immunosorbent assay. mRNA was isolated
from the tissue, and levels of macrophage inflammatory protein
(MIP)-2, monocyte chemoattractant protein (MCP)-1, IL-1, and
IL-1Ra were determined using semiquantitative reverse-
transcription polymerase chain reaction (RT-PCR).
Results: ICA induced in knee joints of C57BL/6 mice caused a
florid inflammation at day 3 after induction. To investigate
whether this arthritis was FcgR-mediated, ICA was induced in
FcR g-chain–/– mice, which lack functional FcgRI and RIII. At
day 3, virtually no inflammatory cells were found in their knee
joints. Levels of mRNA of IL-1, IL-1Ra, MCP-1, and MIP-2,
which are involved in the onset of this arthritis, were
significantly lower in FcR g-chain–/– mice than in control
C57BL/6 mice. Levels of IL-1 protein were also measured. At
6 h after ICA induction, FcR g-chain–/– mice and control
C57BL/6 mice showed similar IL-1 production as measured by
protein level. By 24 h after induction, however, IL-1 production
in the FcR g-chain–/– mice was below the detection limit,
whereas the controls were still producing a significant amount.
To investigate whether the difference in reaction to immune
complexes between the DBA/1 and C57BL/6 mice might be
due to variable expression of FcgRs in the knee joint, expression
in situ of FcgRs in naïve knee joints of these mice was
determined. The monoclonal antibody 2.4G2, which detects
both FcgRII and RIII, stained macrophages from the synovial
lining of DBA/1 mice more intensely than those from C57BL/6
mice. This finding suggests a higher constitutive expression of
FcgRs by macrophages of the autoimmune-prone DBA/1 mice.
To quantify the difference in FcgR expression on macrophages
of the two strains, we determined the occurrence of FcgRs on
peritoneal macrophages by FACS analysis. The levels of FcgR
expressed by macrophages were twice as high in the DBA/1
mice as in the C57BL/6 mice (mean fluorescence, respectively,
440 ± 50 and 240 ± 30 intensity per cell). When peritoneal
macrophages of both strains were stimulated with immune
complexes (HAGGs), we found that the difference in basal
FcgR expression was functional. The stimulated macrophages
from DBA/1 mice had significantly higher IL-1a levels (120 and
135 pg/ml at 24 and 48 h, respectively) than cells from
C57BL/6 mice (45 and 50 pg/ml, respectively).
When arthritis was induced using other arthritogenic triggers
than immune complexes (zymosan, SCW), all the mouse strains
tested (DBA/1, FcR g-chain–/–, and C57BL/6) showed similar
inflammation, indicating that the differences described above are
found only when immune complexes are used to elicit arthritis.
We next compared articular cartilage damage in arthritic joints
of the three mouse strains FcR g-chain–/–, C57BL/6
(intermediate basal expression of FcgRs), and DBA/1 (high
basal expression of FcgRs). Three indicators of cartilage
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Introduction
Rheumatoid arthritis (RA) is characterised by chronic joint
inflammation eventually leading to irreversible cartilage
destruction. IgG-containing immune complexes, such as
rheumatoid factors, are abundant in the synovial tissue of
patients with RA [1,2]. It is still debated what role these
complexes play in the aetiology and pathology of the
disease. Immune complexes communicate with
haematopoietic cells via Fcg receptors (FcgRs) [3–5]. In
recent studies, the importance of these receptors in inflam-
mation and tissue damage has been shown in various
inflammatory diseases, eg autoimmune haemolytic anaemia
and thrombocytopenia [6,7], autoimmune glomerulonephri-
tis [8], and induced glomerulonephritis [9,10]. FcgRs,
which belong to the immunoglobulin superfamily, bind IgG.
Three classes of leucocyte FcgR have been described
(FcgRI, RII, and RIII). Binding of these receptors initiates
signalling cascades that can lead to either activation or
deactivation of effector cells. In mice, cross-linking of FcgRI
and RIII leads to activation [11,12] of intracellular signalling
transduction pathways, whereas stimulation of FcgRIIb
leads to their deactivation [13,14]. Coordinate expression
of activating and inhibitory receptors has been suggested
to drive immune-complex-mediated diseases [15].
damage were investigated: depletion of PGs, chondrocyte
death, and erosion of the cartilage matrix. At day 3 after
induction of ICA, there was no PG depletion in FcR g-chain–/–
mice, whereas PG depletion in the matrix of the C57BL/6 mice
was marked and that in the arthritic DBA/1 mice was even
greater. PG depletion was still massive at days 7 and 14 in the
DBA/1 mice, whereas by day 14 the PG content was almost
completely restored in knee joints of the C57BL/6 mice.
Chondrocyte death and erosion of cartilage matrix, two
indicators of more severe cartilage destruction, were
significantly higher in the DBA/1 than in the C57BL/6 mice,
while both indicators were completely absent in the FcR
g-chain–/– mice. Again, when arthritis was induced using other
triggers (SCW, zymosan), all strains showed similar PG
depletion and no chondrocyte death or matrix erosion. These
findings underline the important role of immune complexes and
FcgRs in irreversible cartilage damage.
Discussion: Our findings indicate that inflammation and
subsequent cartilage damage caused by immune complexes
may be related to the occurrence of FcgRs on macrophages.
The absence of functional FcgRI and RIII prevented
inflammation and cartilage destruction after induction of ICA,
whereas high basal expression of FcgRs on resident joint
macrophages of similarly treated mice susceptible to
autoimmune arthritis was correlated with markedly more
synovial inflammation and cartilage destruction. The difference
in joint inflammation between the three strains was not due to
different susceptibilities to inflammation per se, since intra-
articular injection of zymosan or SCW caused comparable
inflammation. Although extensive inflammatory cell mass was
found in the synovium of all strains after intra-articular injection
of zymosan, no irreversible cartilage damage (chondrocyte
death or matrix erosion) was found. ICA induced in C57BL/6
and DBA/1 mice did cause irreversible cartilage damage at
later time points, indicating that immune complexes and FcgRs
play an important role in inducing irreversible cartilage damage.
Macrophages communicate with immune complexes via Fcg
receptors. Absence of functional activating receptors
completely abrogates the synovial inflammation, as was shown
after ICA induction in FcR g-chain–/– mice. However, the
g-chain is essential not only in FcgRI and RIII but also for FceRI
(found on mast cells) and the T cell receptor (TcR)-CD3
(T cells) complex of gdT cells. However, T, B, or mast cells do
not play a role in this arthritis that is induced by passive
immunisation. Furthermore, this effect was not caused by a
difference in clearance of IgG or complement deposition in the
tissue. In this study, DBA/1 mice, which are susceptible to
collagen-induced autoimmune arthritis and in a recent study
have been shown to react hypersensitively to immune
complexes, are shown to express higher levels of FcgRs on
both synovial and peritoneal macrophages. Because antibodies
directed against the different subclasses of FcgR are not
available, no distinction could be made between FcgRII and
RIII. Genetic differences in DBA/1 mice in genes coding for or
regulating FcgRs may be responsible for altered FcgR
expression. If so, these mouse strains would have a heightened
risk for immune-complex-mediated diseases.
To provide conclusive evidence for the roles of the various
classes of FcgR during ICA, experiments are needed in which
FcgRs are blocked with specific antibodies, or in which
knockout mice lacking one specific class of FcgR are used. The
only available specific antibody to FcgR (2.4G2) has a
stimulatory effect on cells once bound to the receptor, and
therefore cannot be used in blocking experiments. Experiments
using specific knockout mice are now being done in our
laboratory.
Macrophages are the dominant type of cell present in chronic
inflammation during RA and their number has been shown to
correlate well with severe cartilage destruction. Apart from that,
in humans, these synovial tissue macrophages express
activating FcRs, mainly FcgIIIa, which may lead to activation of
these macrophages by IgG-containing immune complexes. The
expression of FcRs on the surface of these cells may have
important implications for joint inflammation and severe
cartilage destruction and therefore FCRs may constitute a new
target for therapeutic intervention.
Full articleDuring RA, the dominant cell type in the joint is the
macrophage. Elegant studies by Bresnihan’s group have
shown a correlation between the number of macrophages
present in the joint and severe cartilage destruction
[16–18]. In other studies, selective elimination of synovial
lining macrophages prior to induction of experimental
arthritis prevented the onset of arthritis and cartilage
destruction. Furthermore, selective removal of lining
macrophages during chronic arthritis significantly downreg-
ulated synovial inflammation [19–22] and partly prevented
exacerbation [23]. Synovial macrophages, which cover the
inside of diarthrodial joints and surround blood vessels in
the synovium, are among the first cells that come in contact
with immune complexes. All three classes of FcgR are
known to be expressed on macrophages in general and on
synovial macrophages in particular [4,24–26] and the
amount and/or ratio of the various types of FcgR expression
might determine joint inflammation and cartilage destruc-
tion. Overexpression, downregulation, or functional impair-
ment of activating FcgRI and RIII on macrophages may
have consequences for inflammation and cartilage destruc-
tion. Differences in basal expression levels of FcgRs may
be genetically linked or related to age [27]. Cytokines such
as IFN-g and TGF-b have been shown to upregulate,
respectively, FcgRI and RIII, whereas IL-4 and IL-13 down-
regulate both receptor classes [4,28–33].
Recently, we observed that when immune complexes were
injected into the knee joints of mice, strains susceptible to
collagen-type-II arthritis (DBA/1 and B10.RIII mice) devel-
oped more severe arthritis than nonsusceptible strains did,
or even developed chronic arthritis [34]. Mouse strains that
are prone to develop autoimmune arthritis may also express
higher levels of FcgRs on their macrophages, thus driving
joint inflammation and cartilage destruction.
To test this hypothesis, we have investigated the role of
FcgRs in inflammation and cartilage damage during
immune-complex-mediated arthritis (ICA). In this model,
arthritis is induced by intra-articular injection of the antigen
into knee joints of mice that were previously passively
immunised against the antigen, by intravenous injection of
specific antibodies [35]. First, synovial inflammation,
cytokine production, and joint destruction were investi-
gated in FcR g-chain knockout (FcR g-chain–/–) mice,
lacking functional FcRI and RIII, and their controls. Then
DBA/1 mice, which are prone to develop collagen-type-II
autoimmune arthritis and express a higher than usual sen-
sitivity for immune complexes, were compared with non-
susceptible C57BL/6 mice, and the expression and
functional relation of Fc receptors on macrophages with
inflammation and cartilage destruction were investigated.
The findings indicate that FcR expression on synovial-
lining macrophages is related to the severity and chron-
icity of synovial inflammation and cartilage destruction
during joint inflammation elicited by immune complexes.
Materials and methods
Animals
Male and female C57BL/6 mice were obtained from
Jackson (Bar Harbor, Maine, USA). DBA/1 mice were
obtained from Bomholdgard (Rye, Denmark). FcR
g-chain–/– mice were kindly given by T Saito [10]. FcR
g-chain–/– mice were backcrossed to C57BL/6 mice for
12 generations. FcR g-chain–/– were also backcrossed to
a DBA/1 background. Mice were fed a standard diet and
tap water ad libitum. Mice were used between the ages of
8 and 12 weeks and weighed 25–30 g.
Chemicals
Poly-L-lysine (PLL), lysozyme, 1-ethyl-3-(3-dimethylamino-
propyl) carbodiimide (EDC), and zymosan A (from Sac-
charomyces cerevisiae) were obtained from Sigma
Chemical Company, St Louis, MO, USA. N,N-dimethyl-
1,3-propanediamine (DMPA) was obtained from BDH
Chemicals Ltd, Poole, UK.
Lysozyme coupling to PLL
Lysozyme was coupled to PLL in accordance with the
method of Danon et al [36]. As described by those authors,
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide was used as
an activator and PLL as a nucleophil. Free carboxyl groups of
the protein were then coupled to amino groups of PLL. The
molecular mass was raised whereas the isoelectric point
remained high, as was determined in a 5% polyacrylamide
slab gel with 0.8% ampholines (pH gradient 3.5–9.5). The
molecular mass appeared to be 74 kD on SDS–PAGE.
Induction of arthritis by immune complexes, zymosan, or SCW
Specific rabbit anti-lysozyme antisera, made as described
elsewhere [35] and made complement-free by heating at
56°C for 30 min, were injected (0.2 ml) intravenously into
mice. ICA was then induced by injecting 3 mg of PLL-
coupled lysozyme into the right knee joint. The left knee
joint was injected with saline solution and used as a
control. As an additional control, some mice were given
normal rabbit serum instead of specific anti-lysozyme.
When PLL-lysozyme was injected into the knee joint
without prior administration of specific anti-lysozyme anti-
bodies, no inflammation or cartilage damage developed, in
either C57BL/6 or DBA/1 mice.
Zymosan (30 mg) was dissolved in 1 ml saline solution by
heating up to 100°C twice and was then sonicated to
obtain a homogeneous suspension. Arthritis was induced
in other mice by injecting 180 mg zymosan into both left
and right knee joints. Fcg-chain knockout mice and the
control strain (C57BL/6) were matched for age and sex.
SCW arthritis was induced by injecting 25 mg SCWs
(rhamnose content), prepared as described elsewhere
[37] and dissolved in 6 ml saline, into the right knee joint
of C57BL/6 and DBA/1 mice.
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Total knee joints of mice were isolated 3 days after induc-
tion of arthritis in Fcg-chain deficient mice and at days 3, 7,
and 14 in C57BL/6 and DBA/1 mice. For standard histol-
ogy, tissue was fixed in 4% formaldehyde, decalcified in
formic acid, and subsequently dehydrated and embedded
in paraffin. Paraffin sections were cut at 7 mm and mounted
on gelatine-coated slides. Haematoxylin/eosin (H&E) stain-
ing was performed to study the inflammatory cells.
Infiltrate and exudate were scored separately. The severity
was determined by two blinded observers, using an arbitrary
score (0–3): 0 = none, 1 = mild, 2 = moderate, and 3 =
maximal cellularity. To study PG depletion from the cartilage
matrix, sections were stained with safranin O and then coun-
terstained with fast green. PG depletion from several carti-
lage surfaces was scored (patella + adjacent femur surface,
lateral condyle femur + adjacent surface tibia plateau, and
medial femoral condyle + adjacent surface tibia plateau).
The severity of depletion was scored by two blinded
observers, using an arbitrary score reflecting the level of
destaining: 0 = none, 1 = mild, 2 = moderate, and 3 =
maximal destaining of cartilage. Chondrocyte death was
scored using H&E-stained sections. The amount of empty
lacunae was given as a percentage of total amount of cells
(empty lacunae + viable chondrocytes). Cartilage erosion
was scored by expressing the amount of eroded cartilage
as a percentage of the cartilage surface.
Detection of Fcg g receptors
To compare expression of FcgRII/RIII by DBA/1 and
C57BL/6 mice, we performed immunohistochemistry using
a rat antibody against murine FcgRII/RIII (2.4G2, Pharmin-
gen, San Diego, CA, USA) [38]. Briefly, cryostat sections
were fixed in acetone vapour for 3 min and endogenous
peroxidase was blocked using 1% H2O2. Sections were
incubated overnight with 2.4G2 (1 mg/ml) in phosphate-
buffered saline (PBS)/0.1% bovine serum albumin (BSA).
Sections were washed in PBS and then incubated with
rabbit anti-rat IgG coupled to biotin (Vector Laboratories,
Burlingame, CA, USA). Then the sections were incubated
with avidin biotin complexes (ABC; Vectastain Elite-kit,
Vector Laboratories) and developed using diaminobenzi-
dine (Sigma Chemical Company, St Louis, MO, USA).
Detection of IgG and C3c
IgG deposited in the tissue by immune-complex formation
was detected on paraffin-embedded knee-joint sections.
Sections were incubated with biotinylated rat anti-rabbit
antibodies (Vector Laboratories) for 1 h. Sections were
washed thoroughly with PBS, incubated with ABC com-
plexes, and developed using the method described above.
C3c was detected using cryostat sections. Sections were
incubated with rat anti-murine C3c (Nordic, Tilburg, The
Netherlands) after acetone fixation and inhibition of
endogenous peroxidase. Isotype-matched antibodies
directed against an irrelevant epitope (Vector) were used
as a negative control. Staining was scored using image
analysis by measuring the mean amount of blue light that
passed through a well-defined location in the tissue
section near the cruciate ligaments.
Analysis by fluorescence-activated cell sorter (FACS)
Peritoneal macrophages of different strains were isolated
from the peritoneal cavity by lavage with ice-cold DMEM/
10% fetal calf serum (FCS)/1% pyruvate. These cells
( 5×1 0 6/100 ml) were incubated with 2.4G2 (5 mg/ml).
They were then washed and incubated with mouse-
adsorbed hamster anti-rat F(ab¢)2 fragments labelled with
fluorescein isothiocyanate (FITC). FACS analysis was per-
formed using a Coulter Epics XL/XL-MCL (Coulter Elec-
tronics Ltd, Mijdrecht, The Netherlands). Omitting the first
antibody and substitution of 2.4G2 for isotype-matched
irrelevant antibodies (DAKO, Glostrup, Denmark) were
used as negative controls. The window was set so that
>95% of cells were F4/80-positive, indicating that >95%
of cells were macrophages.
Stimulation of peritoneal macrophages with heat-
aggregated gamma globulin
Peritoneal macrophages were isolated by peritoneal
lavage using ice-cold DMEM/10% FCS. Cells were put
into 24-well plates (Costar, Acton, MA, USA) at a concen-
tration of 1 × 106 cells/ml. After a 4-day adjustment
period, the culture medium was changed to one contain-
ing heat-aggregated gamma globulin (HAGG) at
100 mg/ml, or a control medium. After 24 or 48 h, the
culture medium was collected. HAGGs were obtained by
heating 10 mg/ml rabbit IgG (Sigma Chemicals, St Louis,
MO, USA) to 63°C for 30 min. After heating, the solution
was centrifuged at 12000 g for 10 min. The concentration
of the HAGG in the supernatant was determined by
reading the absorbance at 280 nm.
Production of inflammatory mediators by synovial tissue
Synovial tissue was isolated by dissection of patellar
tendon and patellar plate containing the patella, tendons,
and synovium, as described earlier [39]. Mediators were
obtained by elution from synovial specimens derived from
six knee joints in 2 ml Roswell Park Memorial Institute
(RPMI) medium for 1 h at room temperature. Washouts
were tested for their bioactive IL-1 levels in an IL-1-sensi-
tive bioassay (NOB-1 assay) and in a radioimmunoassay
(RIA) to determine the total protein levels.
Bioassay for IL-1
IL-1 activity was measured in the one-stage bioassay for
IL-1 as described by Gearing et al [40]. The assay was
performed as a culture of the IL-1-specific thymoma cell
EL-4, designated NOB-1, which produces IL-2 and IL-4 in
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responder CTLL line. Briefly, EL-4 cells were washed
twice and resuspended at 2.5 × 105 cells per ml RPMI
medium containing 5% FCS. The cells were distributed
into 96-well microtitre plates at 2.5 × 104 cells per well in
100-ml volumes. CTLL cells (4 × 103) suspended in 50 ml
RPMI medium were added, followed by appropriate dilu-
tions of test sample to a final volume of 200 ml. After 20 h,
0.5 mCi 3H-thymidine (specific activity 20 Ci/mmol; Amer-
sham Nederland BV, ‘s Hertogenbosch, The Netherlands)
was added to each well. After a 3-h incubation, the con-
tents were harvested, and incorporated activity was deter-
mined. The EL-4 line, from which NOB-1 was derived,
does not incorporate thymidine, because it is deficient in
thymidine kinase, and therefore the incorporation of 3H-
thymidine is a measure of only CTLL proliferation. Maximal
3H-thymidine incorporation in the bioassay in the presence
of IL-1 was between 15000 and 20000 cpm. Culture
media contained only minor concentrations of IL-2 or IL-4,
as was assessed by testing samples with CTLL alone.
Measurement of IL-1a a and IL-1b b protein levels
IL-1 culture supernatants were measured in duplicate by a
nonequilibrium RIA as described elsewhere [41]. Briefly,
100 ml polyclonal rabbit anti-murine IL-1a and IL-1b
(diluted in RIA buffer, pH 7.4) was added to 100 ml of
samples and standards and kept on ice. After vortexing,
the tubes were incubated at 4°C. After 24 h, 100 ml of the
appropriate  125I-labelled IL-1a and b containing approxi-
mately 10000 cpm was added to each tube, and incuba-
tion was continued for a further 24 h at 4°C. RIA buffer
(750 ml) containing 9% (w/v) polyethylene glycol 6000
(Merck Diagnostica, Darmstadt, Germany) and 3% (w/v)
goat anti-rabbit serum was added, to separate bound and
free tracer. The tubes were incubated for 20 min at room
temperature. After centrifugation at 1500 × g for 15 min,
supernatants were quickly drained on adsorbent paper. A
gamma-counter was used to count the radioactivity
remaining on the paper. The radioactivity in control tubes
(the nonspecific binding activity) was subtracted from
samples and standards. The detection limit of the assay
was 20 pg/ml for both IL-1a and IL-1b. 
Measurement of IL-1 receptor antagonist
Protein levels of IL-1 receptor antagonist (IL-1Ra) in syn-
ovial washout specimens were detected using a specific
sandwich enzyme-linked immunosorbent assay (ELISA).
Briefly, microtitre plates were coated with unconjugated
first antibody (anti-IL1Ra: MAB480, R&D Systems, Abing-
don, UK) overnight at 4°C. Subsequently, wells were
blocked using 1% BSA followed by a 3-h incubation with
patella washouts at 37°C. Wells were then incubated with
a biotinylated specific antibody (IL-1Ra: BAF480, R&D
Systems) and a signal enhancement step was performed
by incubating with PolyHRP (CLB, Amsterdam, The
Netherlands). Microtitre plates were developed using
o-phenylene-diamine and optical density was read at
492 nm. Between all steps, a washing episode was
included using PBS/0.1% Tween 20.
Semiquantitative detection of mRNA using reverse-
transcription polymerase chain reaction
Levels of mRNA for four different cytokines/chemokines
were detected using a semiquantitative method. In brief,
mice were killed by cervical dislocation, immediately fol-
lowed by dissection of the patella with adjacent synovial
tissue. Six patellae per group were obtained. Two biopsies
with a diameter of 3 mm were punched from the synovial
tissue, using a biopsy punch (Stiefel, Wachtersbach,
Germany): one from the medial and one from the lateral
aspect of the patella. Three lateral and three medial biop-
sies were pooled (six total), to obtain two samples per
group. The samples were immediately frozen in liquid
nitrogen. Thereafter samples were ground to powder
using a Micro-dismembrator II (B Braun, Melsungen,
Germany) and total RNA was extracted using 1 ml TRIzol
reagent.
One microgram of RNA was used for reverse-transcription
polymerase chain reaction (RT-PCR). Reverse transcrip-
tion of mRNA was done using oligoDT primers, and 1/20
of the cDNA was used in one amplification by polymerase
chain reaction (PCR). PCR was performed at a final con-
centration of 200 mM dNTPs, each primer at 0.1 mM, and
1 unit  Taq polymerase (Life Technologies, Breda, The
Netherlands) in standard PCR buffer. Message for glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH), IL-1b,
IL-1Ra, MCP-1, and MIP-2 was amplified using specific
primers. The primer sequences for IL-1b were: 5¢-
TTGACGGACCCCAAAAGATG-3¢ (sense) and 5¢-
AGAAGGTGCTCATGTCCTCA-3¢ (antisense), for IL-1ra:
5'-TGCTGGGGACCCTACAGTCAC-3¢ (sense) and 5¢-
GCAAGTGCATCATCGTTGTTC-3¢ (antisense), for
MCP-1: 5¢-CTCACCTGCTGCTACTCATTC-3¢ (sense)
and 5¢-GCATGAGGTGGTTGTGAAAA-3¢ (antisense) and
for MIP-2: 5¢-GCTGGCCACCAACCACCAGG-3¢ (sense)
and 5¢-AGCGAGGCACATCAGGTACG-3¢ (antisense).
The PCR-reaction was paused after 20, 23, 26, 29, 32,
35, 38, 41, and 44 cycles at the very end of the extension
phase (72°C) and 5-ml samples were taken. PCR prod-
ucts were separated on 1.6% agarose gel and stained
with ethidium bromide. The results are presented as cycle
number in which the first detectable amount of DNA
appears on the agarose gel. Samples were compared
after correction for GAPDH content for each individual
sample, to rule out confounding by variation of cellularity in
the biopsies.
Statistical analysis
Differences between experimental groups were tested for
significance using the Wilcoxon rank test. P values < 0.05
were considered significant.
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Fcg g receptors are essential for synovial inflammation
during immune-complex-mediated arthritis
To investigate the involvement of Fcg receptors in locally
induced ICA, we used FcR g-chain–/– C57BL/6 mice,
which lack functional FcgRI and RIII. ICA was induced in
knee joints of FcR g-chain–/– mice and control C57BL/6
mice. Histology of total knee joints showed florid inflam-
mation in C57BL/6 mice 3 days after induction of ICA
(Fig. 1b). In knee joints of FcR g-chain–/– mice, however,
virtually no inflammatory cells were observed at day 3 of
ICA (Fig. 1a). Joint inflammation, defined as cells present
in the joint cavity (exudate) and synovium (infiltrate), was
scored. Both exudate and infiltrate were substantial in
C57BL/6 mice whereas, in FcR g-chain–/– mice, cell influx
was virtually absent (Table 1).
To investigate whether FcgRs are involved in the upregula-
tion of inflammatory mediators seen during the first phase
of this arthritis, RT-PCR was performed on synovial speci-
mens from arthritic knee joints. Levels of mRNA of inflam-
matory mediators (IL-1b, IL-1Ra, MCP-1, MIP-2) were
detected semiquantitatively in knockout and control mice,
6 and 24 h after ICA induction (Fig. 2). IL-1b and IL-1Ra
mRNA levels were high in control arthritis and appeared to
be decreased (down to 28) in FcR g-chain–/– mice. MCP-1
and MIP-2 mRNA levels were also diminished in the early
phase of ICA (6 h) relative to the levels of controls
(respectively down to 26 and 24) suggesting downregula-
tion of both polymorphonuclear neutrophils (PMNs) and
monocyte-specific chemokines.
Subsequently, intra-articular production of IL-1 and IL-1Ra
protein during arthritis was measured. Washouts of syn-
ovial specimens from joints of control C57BL/6 mice con-
tained considerable amounts of IL-1 (240 pg/ml) at 6 h
after induction of arthritis; at 24 h, IL-1 levels were
reduced to 70 pg/ml (Table 2). Washouts of arthritic FcR
g-chain–/– joints contained 200 ng/ml IL-1 at 6 h but no
detected IL-1 at 24 h after induction, indicating that in the
absence of functional FcgRI and RIII, a rapid downregula-
tion of IL-1 production is found. IL-1Ra production was
comparable at 6 h in the two strains (respectively 180 and
215 pg/ml) and below the detection limit at 24 h after ICA
induction in both strains (Table 2).
To exclude the possibility that the strong reduction of
inflammation during ICA in FcR g-chain–/– mice is caused
by a lower level of immune complexes which are formed or
retained within the knee joint, deposition of IgG in the
knee joint was detected using biotinylated goat anti-rabbit
IgG. As Table 3 shows, at 6 and 24 h after ICA induction,
no difference was found between FcR g-chain–/– and
C57BL/6 mice in the amount of immune complexes
deposited within the knee joints. We compared deposition
of complement (C3c) in the synovial tissue of both strains
to rule out the possibility that a difference in complement
deposition caused differences in inflammation. Control
and knockout mice showed the same amounts of C3c in
the tissue as was determined by immunohistochemistry
(Table 3).
Expression of Fcg gRII/III is elevated in resident
macrophages of naïve CIA-sensitive mice that are
hypersensitive to immune complexes
In a recent study [36], we noticed that certain mouse
strains that are prone to develop collagen-type-II autoim-
mune arthritis are also particularly susceptible to immune-
complex-induced inflammation. Induction of ICA in the
DBA/1 knee joint resulted in a more severe arthritis than
that in C57BL/6 mice, and this became chronic (Table 1).
Local production of IL-1 was also significantly higher and
more prolonged than in C57BL/6 mice, both at 6 and 24 h
after ICA induction (Table 2). To investigate whether the
enhanced inflammation in DBA/1 mice during ICA was still
mediated by FcRs, FcR g-chain–/– mice were backcrossed
to DBA/1 (DBAg–/–) mice. ICA was induced in these mice
and the inflammation was compared with that in DBAg+/+
littermates. We found that at day 3 after arthritis induction,
arthritis was full-blown in DBAg+/+ mice (arbitrary scores
of 1.0 ± 0.4 for exudate and 1.6 ± 0.3 for infiltrate) but
was completely absent in g-chain-deficient DBA/1 mice
(0.1 ± 0.2 and 0.1 ± 0.1, respectively; not shown).
To examine whether the different reactions in knee joints
of C57BL/6 and DBA/1 mice to immune complexes might
be due to variable local expression of FcgR, expression in
situ of FcgRs in naïve knee joints was determined immuno-
histochemically, using the monoclonal antibody (mAb)
2.4G2 (FcgRII/III). Synovial macrophage-like type A lining
cells and deeper-lying synovial macrophages were the
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Figure 1
Inflammation in H&E-stained sections of mouse knee joints after
induction of immune-mediated arthritis (ICA). (a) Section from FcR
g-chain–/– mouse 3 days after ICA induction. No inflammatory cells are
visible in the joint space (js) or synovium (s). (b) Section from
C57BL/6 (control) mouse 3 days after ICA induction. Florid
inflammation is visible both in the joint space (exudate) and in the
synovium (infiltrate) (orginal magnification 100×). dominant cell types expressing these receptors, as was
seen in double-labeling studies with F4/80 (data not
shown). Interestingly, synovial macrophages of naïve
DBA/1 mice stained more intensely than those of
C57BL/6 mice (Fig. 3), indicating a higher constitutive
expression of FcgRs in lining macrophages of these
autoimmune-prone mice.
To quantify the difference in FcgR expression by
macrophages of the two strains (DBA/1 and C57BL/6),
we further investigated receptor expression on peritoneal
macrophages, using FACS analysis. Macrophages of
DBA/1 mice (mean fluorescence 440 ± 50 intensity per
cell) displayed almost twice the mean fluorescence with
mAb 2.4G2 as those of C57BL/6 mice (240 ± 30 inten-
sity per cell) (Fig. 4). These findings also indicate that
FcgRII/III is significantly upregulated on the membrane of
macrophage populations present in various body compart-
ments of naïve DBA/1 mice.
To further investigate whether a higher basal FcgR expres-
sion on macrophages has consequences for the activation
of cells upon interaction with immune complexes, peri-
toneal macrophages of both strains were incubated with
aggregated IgG and production of IL-1 was determined by
bioassay. Incubation of C57BL/6 cells for 24 or 48 h
caused the release of considerable amounts of bioactive
IL-1 (45 pg/ml at 24 h and 50 pg/ml at 48 h) (Fig. 5). Inter-
estingly, DBA/1 macrophages produced significantly
higher amounts of IL-1 (120 and 135 pg/ml, respectively)
than C57BL/6 mice.
Arthritogenic triggers other than immune complexes cause
comparable inflammation in knee joints of mice that differ
in Fcg gR expression levels
To substantiate the hypothesis that differences in FcR
expression underlie the variation seen during immune-
complex-induced joint inflammation, we injected various
arthritogenic triggers (zymosan, SCWs) that do not act via
FcgRs into the knee joints of three strains of mice (FcR
g-chain–/–, C57BL/6, and DBA/1). A previous study had
shown that when these triggers were used, there was no
difference between DBA/1 and C57BL/6 mice in joint
inflammation [34]. In the present study, when zymosan
was injected into knee joints of FcR g-chain–/– mice, the
inflammation was similar to that in control C57BL/6 mice.
At day 3 after injection, inflammation in FcR g-chain–/–
mice was scored as 1.0 ± 0.4 for infiltrate and 0.9 ± 0.6
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Table 1
Joint inflammation in FcR g g--chain–/–, wild-type C57BL/6, and DBA/1 mice
Days after induction of ICA
13 7 1 4
Mouse strain Infiltrate Exudate Infiltrate Exudate Infiltrate Exudate Infiltrate Exudate
FcRg–/– 0.4 ± 0.1 0.3 ± 0.2 0.1 ± 0.1* 0.1 ± 0.1* ND ND ND ND
C57BL/6 1.4 ± 0.1 0.8 ± 0.2 1.4 ± 0.3 1.5 ± 0.4 1.2 ± 1.2 0.5 ± 0.6 0.4 ± 0.3 0
DBA/1 ND ND 2.1 ± 0.2* 1.8 ± 0.3 3.0 ± 0* 2.5 ± 0.4* 2.1 ± 0.3* 1.6 ± 0.2*
Cellular score in knee joints 3, 7, and 14 days after induction of ICA in knee joints of FcR g-chain–/–, C57BL/6, and DBA/1 mice. The amount of
inflammatory cells in the joint cavity (exudate) and in the synovial layer (infiltrate) were scored blind by two independent observers, on an arbitrary
scale from 0–3 (0 = no; 1 = minor; 2 = moderate; 3 = maximal). Note that FcR g-chain–/– mice show markedly less inflammation and that knee
joints of DBA/1 mice were significantly more inflamed at all time points in comparison with C57BL/6 mice. Data are means of scores for six mice,
and significance (FcR g-chain–/– versus C57BL/6, and DBA/1 versus C57BL/6) was evaluated using the Mann–Whitney U test (*P < 0.05). 
ND, not done.
Figure 2
Semiquantitative mRNA measurements in synovial tissue of FcR
g-chain–/– and C57BL/6 (control) mice. Synovial mRNA levels of IL-1,
IL-1Ra, MCP-1, and MIP-2, 6 and 24 h after induction of ICA. At
certain points during the PCR reaction, samples were put on agarose
gel and electrophoresis was performed. The number of the cycle in
which the first band appeared was found: thus, a low cycle number
means a higher mRNA content. Data were corrected for GAPDH
signal. (Each group: n = 6.)
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in control C57BL/6 mice. These findings indicate that
knee joints of the three strains examined develop compa-
rable, marked inflammation after injection of zymosan or
SCWs. Moreover, IL-1b production in the knee joints
during zymosan-induced arthritis was comparable in
DBA/1 and C57BL/6 mice (Table 2).
Fcg gR expression on macrophages is correlated with
cartilage destruction during immune-complex-mediated
arthritis
Apart from inflammation, absence or overexpression of
FcgRs by local macrophages may also have serious conse-
quences for cartilage destruction. We investigated several
parameters of cartilage destruction (depletion of proteogly-
cans [PGs], chondrocyte death, and erosion of the carti-
lage matrix). Arthritic knee joints of the three strains were
compared at different time points after ICA induction. At
day 3, control C57BL/6 mice showed marked PG deple-
tion in various cartilage surfaces (patella, femur adjacent to
patella, lateral and medial condyle of the femur, and lateral
and medial condyle of the tibia). Strikingly, PGs were not
depleted in arthritic knee joints of the FcR g-chain–/– mice
(Fig. 6a,b; Table 4). In contrast, arthritic DBA/1 knee joints
showed markedly greater depletion of PGs than those of
C57BL/6 mice. Moreover, PG depletion was still severe at
days 7 and 14 in the DBA/1 mice, whereas in the
C57BL/6 mice it was almost fully restored by day 14
http://arthritis-research.com/content/2/6/489
Table 2
IL-1 and IL-1Ra production (pg/ml) in knee joints of mice after induction of immune-complex-mediated arthritis (ICA) and
zymosan-induced arthritis (ZIA)
During ICA During ZIA
IL-1Ra IL-1b IL-1b
Mouse strain At 6 h At 6 h At 24 h At 6 h At 24 h
FcRg–/– 180 ± 15 200 ± 23 <20* ND ND
C57BL/6 215 ± 20 240 ± 21 70 ± 12 >1000 550 ± 30
DBA/1 ND 390 ± 43* 120 ± 15* >1000 565 ± 5
Production of IL-1Ra at 6 h and IL-1b at 6 and 24 h after induction of ICA and ZIA in knee joints of three mouse strains. IL-1b was measured using
a radioimmunoassay. Data are means ± SD of at least 5 mice and were evaluated using the Mann–Whitney U test (*P<0.05). ICA, immune-
complex-mediated arthritis; IL-1Ra, IL-1 receptor antagonist; ND = not done; ZIA, zymosan-induced arthritis.
Table 3
Deposition of IgG and complement factor C3c in knee joints of
mice at various times after induction of immune-complex-
mediated arthritis
IgG C3c
Mouse strain 6 h 24 h 24 h
FcRg–/– 128 ± 6 139 ± 4 152 ± 9
C57Bl/6 (control) 126 ± 4 140 ± 9 155 ± 7
IgG and C3c were studied immunohistochemically. Deposition was
assessed using an image analyser to measure the mean amount of
blue light, as a measure of staining intensity, passing through a defined
area in the tissue. Data are means ± SD for six mice. Significance was
evaluated using Student’s t test.
Figure 3
Expression of FcgRs in naïve knee joints of C57BL/6 and DBA/1 mice
as detected by immunohistochemical staining using specific anti-
FcgRII/III antibodies (mAb: 2.4G2) and subsequent development using
di-aminobenzidine. (a) Naïve C57BL/6 mice. Very light staining of both
synovial lining layer (arrows) and deeper layer.  (b) Naïve DBA/1. Note
the markedly higher staining intensity, especially of the cells of the
synovial lining (arrows) (original magnification 200×). (Fig. 6b–e; Table 4). When ICA was induced in FcR g–/–
mice with a DBA/1 background, PG depletion at day 3
was scored 2.6 ± 0.3 in the Fcg-chain+/+ mice and was
totally absent in the FcR g-chain–/– ones.
Chondrocyte death was measured by determining empty
lacunae in the cartilage matrix and breaks in DNA strands
as evaluated using an in situ cell detection kit (TUNEL
method; data not shown). In knee joints of C57BL/6 mice,
chondrocyte death at day 3 was 5% in the patella and
30% in the adjacent femur. In the knee joints of knockout
mice, chondrocyte death was completely absent (Table 4),
whereas in the DBA/1 mice, it was strikingly higher in both
the patella (50%) and the femur (90%) than in the control
mice (C57BL/6).
Finally, erosion of the cartilage matrix in knee joints was
measured. Whereas no erosion was found in either FcR g-
chain–/– or C57BL/6 mice at day 3 after arthritis induction,
in DBA/1 mice erosion was already considerable by day 3,
and complete loss of the cartilage surface layer up to the
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Figure 4
Expression of FcgRs by resident peritoneal macrophages of C57BL/6
and DBA/1 mice as determined by fluorescence in FACS analysis.
Almost twice as many receptors were expressed in DBA/1 as in
C57BL/6 (control) mice. Cells were isolated from naïve mice using ice-
cold medium and thereafter incubated with an anti-FcgR antibody
(2.4G2) that recognises both FcgRII and RIII. Incubation with FITC-
labeled secondary antibody followed.
0
10
20
30
40
50
60
N
u
m
b
e
r
 
o
f
 
c
e
l
l
s DBA/1
C57Bl/6
Fluorescence
0.1 1000 100 10 1
Figure 5
IL-1 production by peritoneal macrophages. Production of bioactive IL-
1 (pg/ml) by peritoneal macrophages of C57BL/6 and DBA/1 mice 24
and 48 h after stimulation with HAGGs (100mg/ml). IL-1 production
was measured using an IL-1-specific bioassay (NOB assay). The
higher production by macrophages of DBA/1 than of C57BL/6 mice
was significant (*P < 0.02).
0
20
40
60
80
100
120
140
160
180
24 h 48 h
Hours of stimulation
C57BL/6
DBA/1
*
*
B
i
o
a
c
t
i
v
e
 
I
L
-
1
 
p
r
o
d
u
c
t
i
o
n
 
(
p
g
/
m
l
)
Figure 6
Cartilage damage during ICA. Safranin-O-stained knee-joint sections
of FcR g-chain–/–, C57BL/6, and DBA/1 mice 3 and 7 days after
induction of ICA. Proteoglycan depletion was correlated with
destaining of the superficial layer of the cartilage matrix, which is
normally stained red. Both patellar (P) and femoral (F) cartilage are
shown. (a) FcR g-chain–/– 3 days after ICA induction. No proteoglycan
depletion is seen. (b) C57BL/6 mouse 3 days after ICA induction.
Marked destaining of the matrix is found. (c) C57BL/6 mouse 7 days
after ICA induction. The absence of depleted areas suggests that the
matrix has been completely restored. (d) DBA/1 mouse 3 days after
ICA induction. The cartilage matrix is completely depleted, indicating
considerable PG loss. (e) Same mouse strain (DBA/1) as in (d), 7
days after ICA induction. The cartilage matrix seems still devoid of PG,
suggesting that no repair has taken place. Moreover, marked erosion
of the matrix is visible, mainly of the femoral cartilage.tidemark was observed at days 7 and day 14 (Fig. 6d,e;
Table 4).
Severe cartilage destruction in DBA/1 mice is specific for
immune-complex-mediated arthritis
To further substantiate the interpretation that immune
complexes and FcgRs, rather than inflammatory cells,
caused the observed severe joint cartilage destruction,
various concentrations of zymosan were injected into the
knee joints of all three mouse strains (FcR g-chain–/–,
C57BL/6, and DBA/1). Even large amounts of zymosan
(up to 180 mg), although inducing a tremendous influx of
inflammatory cells, failed to induce chondrocyte death or
cartilage erosion. PG depletion at day 3, however, was
scored as 3.6 ± 0.4 in FcR g–/– mice, versus 0.6 ± 0.3 in
C57BL/6 mice. At day 7, mean PG depletion was scored
as 1.8 ± 0.5 in C57BL/6 mice and 1.7 ± 0.8 in DBA/1.
PG depletion in the cartilage matrix in response to
zymosan, therefore, was marked but did not differ between
the three strains.
Discussion
We have found that inflammation and subsequent carti-
lage destruction caused by immune complexes may be
related to the expression of FcgRs on macrophages. Three
strains differing in levels of expression of FcgRs were com-
pared. Absence of functional FcgRI and RIII prevents syn-
ovial inflammation and cartilage destruction after induction
of immune complex arthritis, whereas elevated expression
of FcgR on resident joint macrophages of mice suscepti-
ble for development of autoimmune arthritis is correlated
to markedly more synovial inflammation and cartilage
destruction after induction of ICA. The difference in joint
inflammation seen within the three strains was not due to
genetic differences resulting in a different susceptibility to
inflammation, since injection of zymosan or SCWs caused
comparable inflammation in the three strains.
Mice lacking the FcR g-chain were used to investigate the
role of FcgRs in ICA. The FcR g subunit is essential not
only for functional FcRI and RIII IgG receptors but also for
the high-affinity IgE receptor FceRI and TcR-CD3 complex
of gdT cells. In this passively induced arthritis, B and T
cells do not play a role [35]. Even during the chronic
phase of ICA as seen in the DBA/1 knee joint, no effect on
synovial inflammation was found after giving anti-abTCR
antibodies (data not shown). The high-affinity receptor
FcgRI, which binds IgE, is found on mast cells. A previous
study showed, however, that experimentally induced ICA
in knee joints of mice that are deficient for mast cells
(WBB6F1-W/Wv) [42] was not significantly different from
that in control mice, indicating that mast cells do not play
an important role in ICA.
The findings described above suggest that the observed
joint inflammation is locally regulated by synovial cells.
Earlier studies revealed that macrophage-like type A cells,
which form the dominant population (more than 80%) of
the lining layer of diarthrodial joints in mice, regulate the
onset and chronicity [19–22] as well as the exacerbation
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Table 4
Fc receptors and cartilage damage in knee joints of mice during immune-complex-mediated arthritis
Mouse strain
Index of cartilage damage Day FcRg–/– C57BL/6 DBA/1
PG depletion† 1 0 0.2 ± 0.1 ND
3 0.1 ± 0.1* 2.2 ± 0.5 2.8 ± 0.3*
7 ND 1.5 ± 0.4 3.0 ± 0*
14 ND 0.6 ± 0.4 3.0 ± 0*
Chondrocyte death (%)‡ 10 0 N D
3 0 18 ± 6 35 ± 12
7 ND 20 ± 10 68 ± 24*
14 ND 20 ± 9 98 ± 5*
Matrix erosion§ 10 0 N D
3 0 0 0.4 ± 0.3
7 ND 0.2 ± 0.2 1.5 ± 0.7*
14 ND 0.2 ± 0.2 2.3 ± 0.6*
Cartilage damage was assed using total knee-joint sections stained with safranin O (for PG depletion and matrix erosion) or H&E (for chondrocyte
death). PG depletion was absent in FcRg–/–, moderate in C57BL/6, and high in DBA/1 mice. Irreversible cartilage damage, chondrocyte death, and
erosion of the cartilage matrix, were almost absent in both FcRg–/– and their control C57BL/6 mice, whereas erosion in DBA/1 mice was massive.
To evaluate significance, the Mann–Whitney U-test (*P<0.05) was used. †Scored by two blinded, independent observers. 1 = mild, 2 = moderate,
3 = maximal destaining of cartilage. ‡ Scored by two blinded, independent observers, as the percentage of total cartilage area in the surface layer
(up to the tide mark) containing empty lacunae. § Measured by determining the area in the cartilage surface layer (up to the tidemark) that had been
lost during arthritis by two blinded observers, and expressed using an arbitrary score from 0–3 (0 = no; 1 = minor (0–10%); 2 = moderate
(>10–50%); 3 = maximal (>50–100%). ND = Not done.[23] of experimental arthritis. Selective removal of type A
cells by clodronate-containing liposomes prior to induction
of several experimental arthritides prevented the onset of
arthritis and also the larger part of cartilage destruction
[21,43]. These studies suggested that synovial macro-
phages form an important source of chemotactic factors
and that activation by immune complexes results in produc-
tion of chemokines by these cells. It was also found that
chronicity of synovial inflammation is mostly seen in models
in which immune complexes are present [44]. Immune
complexes communicate with macrophages via FcRs,
especially the FcgRs, which bind IgG. IgG represents the
most dominant immunoglobulin class in the blood and
might be involved in activation of macrophages. Coordinate
expression of activating FcgRI and RIII and the inhibiting
receptor FcgRIIb exposed on joint macrophages probably
determines the reaction to immune complexes [15].
Indeed, we found that the absence of functional FcgRI and
RIII completely abrogated the onset of ICA, as was seen in
knee joints of FcR g-chain–/– mice. The proinflammatory
cytokine IL-1, which has been shown to regulate synovial
inflammation within this model [34,35], was significantly
decreased at protein level 24 h after induction. Semiquan-
titative determination of mRNA levels also suggested
downregulation of IL-1. At 6 h after induction of ICA, no
difference in cytokine production was found between FcR
g-chain–/– mice and controls. It is therefore possible that
the first hours of ICA are mediated by a component other
than FcgRs. This component may very well be comple-
ment. In addition to IL-1, complement split products have
been shown to be important within this model. Depletion
of complement generation by cobra venom factor treat-
ment blocked ICA for the most part [35]. In the present
study, complement C3c deposition did not differ in knee-
joint structures of FcR g-chain–/– and control mice, sug-
gesting that complement activation does not differ
between the two strains; this observation confirms earlier
findings [8]. To further investigate whether complement or
other mediators play a role in the enhanced inflammation
in DBA/1 mice, we compared FcRg-chain–/– mice in a
DBA/1 background with FcR g-chain+/+ mice. ICA did not
develop in FcR g-chain deficient mice with a DBA/1 back-
ground, indicating that in the DBA/1 strain, also, FcRs are
crucial mediators. Another difference may be the removal
of immune complexes from the joint. Earlier studies
revealed that absence of functional FcgRI and RIII retarded
the removal of insoluble immune complexes from the body
[6]. We found, however, no differences in IgG deposition
in the knee joints of the two mouse strains during the first
days. The reason for this may be that the arthritogenic
molecule we use to elicit ICA has an excellent retention,
because of its positive charge. Cationic antigen will be
bound electrostatically to the negatively charged struc-
tures of the joint [35,39]. Moreover, inflammation in the
knee joint may be differently regulated than in other body
compartments. The knee-joint cavity is covered mainly with
macrophages, which are the first cells that come into
contact with the immune complexes during ICA, whereas
the kidney and skin contain a broader range of cell types
handling immune complexes.
Next, we investigated ICA in knee joints of DBA/1 mice
and found that the severity and the chronicity of arthritis
corresponded with a higher level of expression of FcgRs
on macrophages. In contrast, ICA in C57BL/6 mice was
only mild, without a chronic phase. Macrophages in the
knee-joint lining of normal DBA/1 mice stained more
intensely than those of normal C57BL/6 mice, suggesting
a higher basal level of FcgRII/III expression on DBA/1
mice. Furthermore, higher FcgR expression was not limited
to joint macrophages. Peritoneal macrophages showed a
twofold higher expression of FcgRs, suggesting that the
higher basal expression of FcgRII/III is found on all resident
macrophages. Other cell types were also tested for differ-
ences in FcgR expression. No significant differences of
FcgR expression were found on peripheral blood mono-
cytes nor on a mixed B- and T-cell population, indicating
that the differences in expression of FcgRs between
C57BL/6 and DBA/1 are not found on all cells of the
haematopoietic lineage (unpublished results). Antibodies
to FcgRI or FcgRIII are not available and therefore we
could not determine the different classes of FcgR sepa-
rately. Genetic differences in DBA/1 may be responsible
for altered FcgR expression, as Holmdahl et aI have
pointed out [45]. This would imply that this mouse strain is
at higher risk for immune-complex diseases in body com-
partments that contain macrophages. This is in line with
findings in other studies [46]. The finding that FcR g-
chain–/– DBA/1 mice did not show any inflammation when
ICA was induced strongly suggests that, in this strain, full-
blown ICA is also mediated by FcgRs. Thus the differ-
ences in the severity and the chronicity of inflammation
during ICA and in the severity of subsequent cartilage
damage are likely to be caused by differences in FcgR
function or expression. The elevated expression of FcgRs
on macrophages was also functional, as was found in
experiments in vitro in which IL-1 production was mea-
sured after stimulation of macrophages with HAGGs. ICA
induction caused much higher levels and longer-lasting
production of IL-1 in the knee joints of DBA/1 mice than in
the control C57BL/6 mice. IL-1 may well be the factor
responsible for the chronicity of the synovial inflammation.
Although IL-1 levels at day 3 were found to be below the
detection limit of the RIA, blocking of IL-1 with anti-IL-1
antibodies starting at day 3 after ICA induction abrogated
the chronic phase completely [34].
In addition to inflammation, cartilage destruction was also
investigated. In earlier studies, we found that only in those
experimental-arthritis models in which immune complexes
are present was severe, irreparable cartilage damage
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suffer irreparable cartilage damage, although a tremen-
dous influx of inflammatory cells in the joint was observed.
In FcR g-chain–/– mice, depletion of PG was entirely
absent during ICA. In knee joints of DBA/1 mice, loss of
PG from the cartilage matrix was more severe than in
C57BL/6 mice. This finding is in line with the respective
expression of FcgR on macrophages in these strains and
suggests that activation of FcgR may be one of the mecha-
nisms mediating PG loss. Activation of macrophages by
FcgRI and RIII leads to the release of IL-1 [47,48], which is
the dominant cytokine involved in inhibition of PG synthe-
sis [49,50] and production of aggrecan-degrading
enzymes [51,52]. Depletion of PG within this model is
probably mediated by aggrecanase [44], an enzyme that
recently was identified as a metalloproteinase of the
ADAM (A disintegrin and metalloproteinase) family [53].
Aggrecanase neoepitopes were abundantly found during
the first phase of this arthritis [44]. Injection of zymosan
into the knee joints of the three strains we studied was fol-
lowed by a comparable depletion of PG; this finding sug-
gests that the three strains have similar potencies to
produce aggrecanase.
Severe cartilage destruction, like chondrocyte death and
cartilage erosion, was found only in DBA/1 mice. During
the acute phase, PMNs constitute the dominant cell type
present in the joint, whereas during the chronic phase,
macrophages are the predominant cell type present in the
synovium and synovial cavity. FcgR activation on both
PMNs and macrophages may lead to the release of
oxygen and nitrogen radicals, which in high concentrations
can kill chondrocytes either by necrosis or apoptosis
[54,55] or may activate latent enzymes in the matrix. Acti-
vated macrophages form an important source of latent
metalloproteinases such as stromelysin and collagenase;
after activation, these enzymes are involved in degradation
of the collagen matrix, resulting in severe cartilage
destruction [56,57]. Immune complexes activate
macrophages in the synovium, causing the release of
enzymes that are hindered in their activity by large
amounts of inhibitors present in the synovial fluid. Immune
complexes present on the cartilage surface may cause
PMNs or macrophages to attach to this surface, as we
have seen by clear pannus formation on the cartilage
during chronic arthritis in the DBA/1 joint. This attachment
to the cartilage surface may cause release of enzymes that
directly penetrate the cartilage matrix thus escaping from
their inhibitors (manuscript in preparation).
The present findings partly underline the findings in our
previous study, in which an antigen-induced arthritis was
produced in FcR g–/– mice [58], in the sense that stimula-
tion of FcgRs by immune complexes seems necessary in
order to induce irreversible cartilage damage. However, in
contrast to our present findings, antigen-induced arthritis
in FcR g-chain–/– mice did not significantly reduce joint
inflammation. This indicates that within that model, FcRs
do not play any role in the chronic phase of inflammation,
but are of utmost importance in the induction of severe
cartilage damage.
To provide conclusive evidence of the role of various
classes of FcgR during ICA, experiments are needed in
which FcgRs are blocked with specific antibodies, or in
which knockout mice are used that lack one of the specific
classes of FcgR. However, specific antibodies to FcgRs
(2.4G2), once bound to the receptor, have a stimulatory
effect and therefore cannot be used in blocking experi-
ments. Experiments using specific knockout mice are
therefore now being performed in our laboratory.
Macrophages are the dominant type of cell present in
chronic inflammation during RA and their number has
been shown to correlate well with severe cartilage
destruction [16–18]. Apart from that, in humans, these
macrophages express activating Fc receptors, mainly
FcgIIIa [26], which may lead to activation of these cells by
IgG-containing immune complexes. Fc receptor expres-
sion on the surface of these cells may have important
implications for joint inflammation and severe cartilage
destruction and may form new targets for therapeutic
intervention.
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